FdaApplication
ANDA 202846
Identifiers
- fda_app_no: ANDA202846
Properties
| Property | Value |
|---|---|
| applicant_name | INVAGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2014-02-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHENTERMINE HYDROCHLORIDE | PHENTERMINE HYDROCHLORIDE | 37.5MG | CAPSULE;ORAL |
1 product